Battenin antibody
Principal name
Battenin antibody
Alternative names for Battenin antibody
Protein CLN3, Batten disease protein, BTS
Gene ID
1201 (CLN3)
Ncbi ID
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection))
Background of Battenin antibody
- Kit Component:
- - KN201243G1, CLN3 gRNA vector 1 in pCas-Guide vector
- KN201243G2, CLN3 gRNA vector 2 in pCas-Guide vector
- KN201243D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Western Blot analysis of CLN3 expression in transfected 293T cell line by CLN3 monoclonal antibody (M03), clone 1G10.Lane 1: CLN3 transfected lysate(47.623 KDa).Lane 2: Non-transfected lysate.
CLN3 MaxPab rabbit polyclonal antibody. Western Blot analysis of CLN3 expression in mouse kidney.
Western Blot analysis of CLN3 expression in transfected 293T cell line (H00001201-T02) by CLN3 MaxPab polyclonal antibody.Lane 1: CLN3 transfected lysate(47.60 KDa).Lane 2: Non-transfected lysate.
CRISPR
| Catalog No. | Species | Donor Vector | |
|---|---|---|---|
| KN201243 | CLN3 - human gene knockout kit via CRISPR |
||
 |
Human | GFP-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN201243BN | CLN3 - human gene knockout kit via CRISPR |
||
|
Human | mBFP-Neo |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN201243LP | CLN3 - human gene knockout kit via CRISPR |
||
|
Human | Luciferase-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN201243RB | CLN3 - human gene knockout kit via CRISPR |
||
|
Human | RFP-BSD |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP324971 | Battenin (transcript variant 1) |
||||
| Purified recombinant protein of Homo sapiens ceroid-lipofuscinosis, neuronal 3 (CLN3), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€680.00
|
|
| OriGene Technologies, Inc. | |||||
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC201243L2V | Lenti ORF particles, CLN3 (mGFP-tagged) - Human ceroid-lipofuscinosis, neuronal 3 (CLN3), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,082.00
|
|
| OriGene Technologies, Inc. | ||
| RC201243L1V | Lenti ORF particles, CLN3 (Myc-DDK tagged) - Human ceroid-lipofuscinosis, neuronal 3 (CLN3), transcript variant 2 , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€969.00
|
|
| OriGene Technologies, Inc. | ||
